A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene

A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene
复制标题

DOI:
10.2169/internalmedicine.3737-19
复制
发表时间:
2020-01-01
期刊:
影响因子:
1.2
通讯作者:
Kawashiri, Masa-aki
Kawashiri, Masa-aki
中科院分区:
医学4区
文献类型:
--
作者:
Tada, Hayato;Okada, Hirofumi;Kawashiri, Masa-aki

文献摘要

被引文献

相似文献

我们提出了第一例日本患者的家族性低β-脂蛋白血症(FHBL)引起的蛋白质截短变异的前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK 9)基因。一名34岁的女性因低密度脂蛋白(LDL)-胆固醇血症(34 mg/dL)被转诊至我院。她没有低β脂蛋白血症的任何继发原因。她的父亲和妹妹也表现出低LDL胆固醇水平。我们在其中鉴定了PCSK 9基因中的蛋白质截短变体(c.1090_1091del/p.Pro364ArgfsTer62)。他们都没有表现出动脉粥样硬化性心血管疾病,也没有任何其他并发症与低LDL胆固醇,包括脂肪肝,神经认知障碍,或脑血管病。
We present the first case of a Japanese patient with familial hypobetalipoproteinemia (FHBL) caused by a protein-truncating variant in the proprotein convertase subtilisin/kexin type 9 (PCSK9) gene. A 34-year-old woman was referred to our hospital due to her low low-density lipoprotein (LDL)-cholesterolemia (34 mg/dL). She did not have any secondary causes of hypobetalipoproteinemia. Her father and her younger sister also exhibited low LDL cholesterol levels. We identified a protein-truncating variant in the PCSK9 gene (c.1090_1091del/p.Pro364ArgfsTer62) among them. None of them exhibited atherosclerotic cardiovascular diseases nor any other complications associated with low LDL cholesterol, including fatty liver, neurocognitive disorders, or cerebral hemorrhaging.